glp 1 and muscle pain Why GLP-1 Weight Loss Drugs May Cause Unexpected Back Glucagon-like peptide-1 receptor agonists and

Description

Despite the substantial amount of literature proposing the advantages of using SGLT2is + GLP-1RAs, a retrospective cross-sectional two-center study conducted in Riyadh, Saudi Arabia (JanuaryDecember 2020), showed that physicians were under-prescribing these drugs

Protocol 1: the gentle start (for GI-sensitive individuals) Goal: Minimize side effects completely while building to a therapeutic dose Best for: People with histories of medication sensitivity, IBS, acid reflux, or those who tried standard tirzepatide and could not tolerate it Complete schedule: Weeks 1-2: 0.125 mg weekly Weeks 3-4: 0.25 mg weekly Weeks 5-6: 0.5 mg weekly Weeks 7-8: 0.75 mg weekly Weeks 9-10: 1.0 mg weekly Weeks 11-14: 1.5 mg weekly Weeks 15-18: 2.0 mg weekly Weeks 19-22: 2.5 mg weekly Weeks 23-26: 5.0 mg weekly Time to therapeutic dose: 22-26 weeks Expected results: Minimal GI discomfort, gradual appetite reduction beginning around weeks 7-10, meaningful weight loss starting around weeks 15-18 This protocol takes nearly six months to reach 5 mg, but for someone who previously abandoned treatment due to side effects, six months on treatment beats three weeks of misery followed by quitting

He said the approach could lead to more consistent drug levels and improve how well patients tolerate semaglutide, reducing some of its common side effects such as nausea and vomiting

The reviewed papers focused on different populations: the most represented populations where those of healthy participants (14 studies) and individuals with overweight and obesity (13 studies)